PHIRE

PHIRE

Ricerca nanotecnologica

Milano, Lombardia 215 follower

Photoacoustic Imaging and artificial intelligence-based theranostic approach for cancer.

Chi siamo

Health programs crave for diagnostic imaging and eradication of chemoresistant neoplastic lesions smaller than 1 mm of size. PHIRE aims at bringing closer to market a novel high-resolution theranostic medical device effective in the clinical applications for lesions <1 mm, ready for application in human bladder cancer and effective both in male and female patients. The Consortium is composed by hospital, academia and industrial researches located in Italy (San Raffaele Hospital and University of Bologna), United Kingdom (Ascend Technologies LTD), The Netherlands (Fujifilm Visualsonics) and Belgium (META Group). Funding by the Horizon Europe programme, under GA No. 101113193

Settore
Ricerca nanotecnologica
Dimensioni dell’azienda
11-50 dipendenti
Sede principale
Milano, Lombardia
Tipo
Società di persone
Data di fondazione
2023
Settori di competenza
bladder cancer, diagnostic imaging, artificial intelligence, nano-materials, health, theranostic e research project

Località

Aggiornamenti

Pagine simili